(Q29614459)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

30 April 2017

0 references

1 reference

1

Poynard T

1 reference

30 April 2017

Bedossa P

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

30 April 2017

Opolon P

series ordinal

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

22 March 1997

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

30 April 2017

volume

349

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

30 April 2017

page(s)

825-32

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

30 April 2017

issue

9055

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9121257

Epidemiology of hepatitis C in the West

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

The nomenclature of chronic active hepatitis: an obituary.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Histopathology of chronic hepatitis C in relation to epidemiological factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

The long-term pathological evolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: promises and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021

Blood-borne non-A, non-B hepatitis: hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907642-8

7 January 2021